NDC 51662-1389 – Lidocaine Hci
Lidocaine Hydrochloride 20 mg/mL · Jelly · Topical
Product NDC51662-1389
Product details
- Brand name
- Lidocaine Hci
- Generic name
- Lidocaine Hci
- Labeler
- HF Acquisition Co LLC, DBA HealthFirst
- Dosage form
- Jelly
- Route
- Topical
- Marketing category
- ANDA · ANDA086283
- Marketed since
- October 18, 2019
- Listing expires
- December 31, 2026
- Pharmacologic class
- Amide Local Anesthetic; Antiarrhythmic
Active ingredients
- Lidocaine Hydrochloride 20 mg/mL
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 51662-1389-1 | 5 mL in 1 VIAL, SINGLE-DOSE (51662-1389-1) | Oct 18, 2019 |
| 51662-1389-3 | 25 POUCH in 1 CASE (51662-1389-3) / 1 VIAL, SINGLE-USE in 1 POUCH (51662-1389-2) / 5 mL in 1 VIAL, SINGLE-USE | Jan 19, 2023 |
Other Lidocaine Hci products
- 51662-1232 Lidocaine Hydrochloride 10 mg/mL; Epinephrine 10 ug/mL · Injection, Solution · HF Acquisition Co LLC, DBA HealthFirst
- 51662-1233 Lidocaine Hydrochloride 20 mg/mL · Injection, Solution · HF Acquisition Co LLC, DBA HealthFirst
- 51662-1364 Lidocaine Hydrochloride 20 mg/mL · Injection, Solution · HF Acquisition Co LLC, DBA HealthFirst
- 51662-1382 Lidocaine Hydrochloride 20 mg/mL · Injection · HF Acquisition Co LLC, DBA HealthFirst
- 51662-1384 Lidocaine Hydrochloride 20 mg/mL · Injection, Solution · HF Acquisition Co LLC, DBA HealthFirst
- 51662-1416 Lidocaine Hydrochloride 5 mg/mL · Injection, Solution · HF Acquisition Co LLC, DBA HealthFirst
- 51662-1422 Lidocaine Hydrochloride 20 mg/mL · Injection, Solution · HF Acquisition Co LLC, DBA HealthFirst
- 51662-1461 Lidocaine Hydrochloride 10 mg/mL · Injection, Solution · HF Acquisition Co LLC, DBA HealthFirst
- 51662-1543 Lidocaine Hydrochloride 20 mg/mL · Injection, Solution · HF Acquisition Co LLC, DBA HealthFirst
- 73352-204 Lidocaine Hydrochloride 40 mg/g · Cream · Trifluent Pharma, LLC